Description

Opdivo Nivolumab 100mg Injection: Uses, Side Effects, and Precautions

Opdivo Nivolumab 100mg Injection is a monoclonal antibody designed to enhance the immune system?s ability to fight cancer. It is commonly used to treat lung cancer, melanoma, kidney cancer, and Hodgkin?s lymphoma. By blocking the PD-1 receptor, it helps immune cells attack cancer more effectively.

Dosage and Administration
Administered as an intravenous infusion by a healthcare professional.
Dosage depends on the type and stage of cancer.
Typically given every 2 to 4 weeks.

Common Side Effects

Fatigue and weakness
Nausea and vomiting
Skin rash and itching
Diarrhea or constipation

Serious Side Effects

Immune-related reactions affecting the lungs, liver, or intestines
Endocrine gland dysfunction (thyroid, adrenal glands)
Severe infusion reactions (fever, chills, difficulty breathing)
Liver toxicity (jaundice, dark urine)

Precautions and Warnings

Requires regular liver and kidney function monitoring.
May cause immune-related side effects that require corticosteroid treatment.
Not recommended during pregnancy or breastfeeding.
Use with caution in individuals with autoimmune disorders.

Disclaimer:
Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.